Omeprazolo Almus Pharma (Omeprazole)

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions.

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining.
• Erosive oesophagitis: accelerates mucosal healing and reduces further erosion.
• Peptic ulcer disease: supports ulcer healing and prevents recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.
• Helicobacter pylori eradication regimens (as adjunct): enhances eradication success when combined with antibiotics.

• Omeprazole selectively and irreversibly inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of gastric parietal cells. By blocking this final step of acid production, it markedly lowers gastric acidity, allowing damaged mucosa to heal and reducing reflux‑related symptoms.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

• Headache: mild, transient headache reported in many patients.
• Diarrhoea: loose stools that usually resolve without intervention.
• Abdominal pain: mild discomfort or cramping.
• Nausea: occasional feeling of queasiness.
• Flatulence: increased intestinal gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis linked to altered gut flora.
• Acute interstitial nephritis: sudden kidney inflammation.
• Hypomagnesemia: low magnesium levels with prolonged use.
• Stevens‑Johnson syndrome: rare severe skin reaction.
• Fracture risk: possible reduction in bone mineral density with long‑term therapy.

Before initiating therapy, consider the following safety points.

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review concomitant medications: omeprazole can affect drug absorption.
• Evaluate for H. pylori infection: may require combination therapy.
• Use the lowest effective dose: limit duration to the shortest necessary period.
• Monitor for long‑term adverse effects: bone health and magnesium levels.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Omeprazole can modify the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
• Atazanavir: markedly decreased absorption, compromising HIV therapy.
• Dasatinib: lowered plasma concentrations, reducing oncologic efficacy.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR, requiring more frequent monitoring.
• Methotrexate: elevated serum levels, especially with high‑dose regimens.
• Digoxin: modest rise in serum concentration, may need dose adjustment.